Add to ORKGPharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growt
1 A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surfac...
RapidCaP, a novel GEM model for analysis and therapy of metastatic prostate cancer reveals Myc as a ...
DISTRIBUTION STATEMENT: x Approved for public release; distribution unlimited The views, opinions an...
TITLE: Molecular targeting of prostate cancer during androgen ablation: inhibition o
TITLE: Molecular targeting of prostate cancer during androgen ablation: inhibition o
Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer...
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited
1 In vitro and in vivo anti-tumor effects of cytotoxic camptothecin-bombesin conjugates are mediated...
Context-dependent pharmacology exhibited by negative allosteric modulators of metabotropic glutamate...
vivo activity of combined PI3K/mTOR and MEK-inhibition in a KrasG12D;Pten deletion mouse model of ov...
Inhibition of c-Myc down-regulation by sustained ERK activation prevents the antimetabolite methotre...
Prolonged early G1 arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic ki...
RapidCaP, a novel GEM model for analysis and therapy of metastatic prostate cancer reveals Myc as a ...
Contains fulltext : 172475.pdf (publisher's version ) (Open Access)Significant pro...
RapidCaP, a novel GEM model for analysis and therapy of metastatic prostate cancer reveals Myc as a ...
1 A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surfac...
RapidCaP, a novel GEM model for analysis and therapy of metastatic prostate cancer reveals Myc as a ...
DISTRIBUTION STATEMENT: x Approved for public release; distribution unlimited The views, opinions an...
TITLE: Molecular targeting of prostate cancer during androgen ablation: inhibition o
TITLE: Molecular targeting of prostate cancer during androgen ablation: inhibition o
Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer...
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited
1 In vitro and in vivo anti-tumor effects of cytotoxic camptothecin-bombesin conjugates are mediated...
Context-dependent pharmacology exhibited by negative allosteric modulators of metabotropic glutamate...
vivo activity of combined PI3K/mTOR and MEK-inhibition in a KrasG12D;Pten deletion mouse model of ov...
Inhibition of c-Myc down-regulation by sustained ERK activation prevents the antimetabolite methotre...
Prolonged early G1 arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic ki...
RapidCaP, a novel GEM model for analysis and therapy of metastatic prostate cancer reveals Myc as a ...
Contains fulltext : 172475.pdf (publisher's version ) (Open Access)Significant pro...
RapidCaP, a novel GEM model for analysis and therapy of metastatic prostate cancer reveals Myc as a ...
1 A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surfac...
RapidCaP, a novel GEM model for analysis and therapy of metastatic prostate cancer reveals Myc as a ...
DISTRIBUTION STATEMENT: x Approved for public release; distribution unlimited The views, opinions an...